FDG-PET detected thyroid incidentalomas: Need for further investigation?

被引:124
作者
Are, Chandrakanth
Hsu, John F.
Schoder, Heiko
Shah, Jatin P.
Larson, Steve M.
Shaha, Ashok R.
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Head & Neck Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg Oncol, New York, NY 10021 USA
[3] Wyckoff Hts Med Ctr, Dept Surg, Brooklyn, NY 11237 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Radiol, Nucl Med Serv, New York, NY 10021 USA
关键词
FDG-PET scan; thyroid; incidentalomas; risk of malignancy;
D O I
10.1245/s10434-006-9181-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Incidental thyroid abnormalities are increasingly detected in patients undergoing PET scans. The aim of this study was to review our experience with the management of PET detected thyroid incidentalomas in a large single institution series. Methods: All PET scans performed from May 2003 to July 2005 were reviewed and patients with incidental thyroid abnormalities were identified. From this group, patients that underwent further investigation were analyzed. Data relating to PET scan findings, FNA diagnoses, operative details, and histopathology was reviewed. Results: In 8,800 patients, 16,300 PET scans were performed of whom 263 patients (2.9% of patients and 1.6% of PET scans) had findings positive for thyroid abnormality. Thyroid malignancy was noted in 42% (24 patients) of the 57 patients that underwent FNA. In the group of 27 patients that were subjected to operative intervention, 74% (20 patients) were noted to have a malignant diagnosis. The final histopathology revealed primary thyroid carcinoma in all these 20 patients (19 patients with papillary carcinoma and one patient with primary thyroid lymphoma). The factors that correlated with an increased risk of malignancy were the presence of physical finding (p = 0.01) and focal (p < 0.01) or unilateral uptake (p < 0.01) on PET scan. The average SUV was not useful in differentiating benign (9.2) from malignant lesions (8.2, p = 0.7). Conclusions: PET detected incidental thyroid abnormalities are rare. In patients with positive PET scan findings and suspicious features, the incidence of primary thyroid malignancy is very high. These patients warrant further investigation followed by possible operative intervention.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 25 条
[1]   Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography [J].
Boerner, AR ;
Voth, E ;
Theissen, P ;
Wienhard, K ;
Wagner, R ;
Schicha, H .
THYROID, 1998, 8 (09) :765-772
[2]  
Chen YK, 2005, ANTICANCER RES, V25, P1421
[3]   Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma [J].
Chen, YK ;
Liu, FY ;
Yen, RF ;
Kao, CH .
ACADEMIC RADIOLOGY, 2003, 10 (08) :835-839
[4]   Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography [J].
Cohen, MS ;
Arslan, N ;
Dehdashti, F ;
Doherty, GM ;
Lairmore, TC ;
Brunt, LM ;
Moley, JF .
SURGERY, 2001, 130 (06) :941-946
[5]   Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer [J].
de Groot, JWB ;
Links, TP ;
Jager, PL ;
Kahraman, T ;
Plukker, JTM .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (08) :786-794
[6]   Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer:: results of a multicentre study [J].
Diehl, M ;
Risse, JH ;
Brandt-Mainz, K ;
Dietlein, M ;
Bohuslavizki, KH ;
Matheja, P ;
Lange, H ;
Bredow, J ;
Körber, C ;
Grünwald, F .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (11) :1671-1676
[7]   F-18FDG PET in Insular Thyroid Cancer [J].
Diehl, M ;
Graichen, S ;
Menzel, C ;
Lindhorst, E ;
Grünwald, F .
CLINICAL NUCLEAR MEDICINE, 2003, 28 (09) :728-731
[8]  
Erdi YE, 2004, J NUCL MED, V45, P813
[9]   Whole-body positron emission tomography: Normal variations, pitfalls, and technical considerations [J].
Gordon, BA ;
Flanagan, FL ;
Dehdashti, F .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 169 (06) :1675-1680
[10]  
Hsu CH, 2002, J FORMOS MED ASSOC, V101, P459